Articles published by G1 Therapeutics
![](https://ml.globenewswire.com/media/2cdc354f-0f17-4fb5-a670-1e03222cbbf3/small/g1-logo-2022-reg-png.png)
G1 Therapeutics Provides Second Quarter 2024 Financial Results and Operational Highlights
August 08, 2024
From G1 Therapeutics
Via GlobeNewswire
Tickers
GTHX
![](https://ml.globenewswire.com/media/2cdc354f-0f17-4fb5-a670-1e03222cbbf3/small/g1-logo-2022-reg-png.png)
![](https://ml.globenewswire.com/media/2cdc354f-0f17-4fb5-a670-1e03222cbbf3/small/g1-logo-2022-reg-png.png)
![](https://ml.globenewswire.com/media/2cdc354f-0f17-4fb5-a670-1e03222cbbf3/small/g1-logo-2022-reg-png.png)
![](https://ml.globenewswire.com/media/2cdc354f-0f17-4fb5-a670-1e03222cbbf3/small/g1-logo-2022-reg-png.png)
![](https://ml.globenewswire.com/media/2cdc354f-0f17-4fb5-a670-1e03222cbbf3/small/g1-logo-2022-reg-png.png)
![](https://ml.globenewswire.com/media/2cdc354f-0f17-4fb5-a670-1e03222cbbf3/small/g1-logo-2022-reg-png.png)
G1 Therapeutics Provides First Quarter 2024 Financial Results and Operational Highlights
May 01, 2024
From G1 Therapeutics
Via GlobeNewswire
Tickers
GTHX
![](https://ml.globenewswire.com/media/2cdc354f-0f17-4fb5-a670-1e03222cbbf3/small/g1-logo-2022-reg-png.png)
G1 Therapeutics and Pepper Bio Announce Global (Excluding Asia-Pac) License Agreement for Lerociclib
May 01, 2024
From G1 Therapeutics
Via GlobeNewswire
Tickers
GTHX
![](https://ml.globenewswire.com/media/2cdc354f-0f17-4fb5-a670-1e03222cbbf3/small/g1-logo-2022-reg-png.png)
G1 Therapeutics Provides Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights
February 28, 2024
From G1 Therapeutics
Via GlobeNewswire
Tickers
GTHX
![](https://ml.globenewswire.com/media/2cdc354f-0f17-4fb5-a670-1e03222cbbf3/small/g1-logo-2022-reg-png.png)
![](https://ml.globenewswire.com/media/2cdc354f-0f17-4fb5-a670-1e03222cbbf3/small/g1-logo-2022-reg-png.png)
G1 Therapeutics Provides Corporate Update at the 42nd Annual J.P. Morgan Healthcare Conference
January 08, 2024
From G1 Therapeutics
Via GlobeNewswire
Tickers
GTHX
![](https://ml.globenewswire.com/media/2cdc354f-0f17-4fb5-a670-1e03222cbbf3/small/g1-logo-2022-reg-png.png)
![](https://ml.globenewswire.com/media/2cdc354f-0f17-4fb5-a670-1e03222cbbf3/small/g1-logo-2022-reg-png.png)
G1 Therapeutics Announces Upcoming Presentation at the 2023 San Antonio Breast Cancer Symposium
November 29, 2023
From G1 Therapeutics
Via GlobeNewswire
Tickers
GTHX
![](https://ml.globenewswire.com/media/2cdc354f-0f17-4fb5-a670-1e03222cbbf3/small/g1-logo-2022-reg-png.png)
G1 Therapeutics Provides Third Quarter 2023 Financial Results and Operational Highlights
November 01, 2023
From G1 Therapeutics
Via GlobeNewswire
Tickers
GTHX
![](https://ml.globenewswire.com/media/2cdc354f-0f17-4fb5-a670-1e03222cbbf3/small/g1-logo-2022-reg-png.png)
![](https://ml.globenewswire.com/media/2cdc354f-0f17-4fb5-a670-1e03222cbbf3/small/g1-logo-2022-reg-png.png)
![](https://ml.globenewswire.com/media/2cdc354f-0f17-4fb5-a670-1e03222cbbf3/small/g1-logo-2022-reg-png.png)
G1 Therapeutics Announces Upcoming Presentations at the 2023 ASCO Quality Care Symposium
October 16, 2023
From G1 Therapeutics
Via GlobeNewswire
Tickers
GTHX
![](https://ml.globenewswire.com/media/2cdc354f-0f17-4fb5-a670-1e03222cbbf3/small/g1-logo-2022-reg-png.png)
G1 Therapeutics Provides Second Quarter 2023 Financial Results and Operational Highlights
August 02, 2023
From G1 Therapeutics
Via GlobeNewswire
Tickers
GTHX
![](https://ml.globenewswire.com/media/2cdc354f-0f17-4fb5-a670-1e03222cbbf3/small/g1-logo-2022-reg-png.png)
![](https://ml.globenewswire.com/media/2cdc354f-0f17-4fb5-a670-1e03222cbbf3/small/g1-logo-2022-reg-png.png)
![](https://ml.globenewswire.com/media/2cdc354f-0f17-4fb5-a670-1e03222cbbf3/small/g1-logo-2022-reg-png.png)
![](https://ml.globenewswire.com/media/2cdc354f-0f17-4fb5-a670-1e03222cbbf3/small/g1-logo-2022-reg-png.png)
![](https://ml.globenewswire.com/media/2cdc354f-0f17-4fb5-a670-1e03222cbbf3/small/g1-logo-2022-reg-png.png)
G1 Therapeutics Provides First Quarter 2023 Financial Results and Operational Highlights
May 03, 2023
From G1 Therapeutics
Via GlobeNewswire
Tickers
GTHX
![](https://ml.globenewswire.com/media/2cdc354f-0f17-4fb5-a670-1e03222cbbf3/small/g1-logo-2022-reg-png.png)
G1 Therapeutics Provides Fourth Quarter and Full Year 2022 Financial Results and Operational Highlights
March 01, 2023
From G1 Therapeutics
Via GlobeNewswire
Tickers
GTHX
![](https://ml.globenewswire.com/media/2cdc354f-0f17-4fb5-a670-1e03222cbbf3/small/g1-logo-2022-reg-png.png)
![](https://ml.globenewswire.com/media/2cdc354f-0f17-4fb5-a670-1e03222cbbf3/small/g1-logo-2022-reg-png.png)
G1 Therapeutics Announces Upcoming 2023 Readouts from its Phase 2 and Pivotal Phase 3 Clinical Trials of Trilaciclib
January 09, 2023
From G1 Therapeutics
Via GlobeNewswire
Tickers
GTHX
![](https://ml.globenewswire.com/media/2cdc354f-0f17-4fb5-a670-1e03222cbbf3/small/g1-logo-2022-reg-png.png)
![](https://ml.globenewswire.com/media/2cdc354f-0f17-4fb5-a670-1e03222cbbf3/small/g1-logo-2022-reg-png.png)
G1 Therapeutics Announces Closing of Offering of Common Stock
November 22, 2022
From G1 Therapeutics
Via GlobeNewswire
Tickers
GTHX
![](https://ml.globenewswire.com/media/2cdc354f-0f17-4fb5-a670-1e03222cbbf3/small/g1-logo-2022-reg-png.png)
G1 Therapeutics Announces Pricing of Offering of Common Stock
November 17, 2022
From G1 Therapeutics
Via GlobeNewswire
Tickers
GTHX
![](https://ml.globenewswire.com/media/2cdc354f-0f17-4fb5-a670-1e03222cbbf3/small/g1-logo-2022-reg-png.png)
G1 Therapeutics Announces Proposed Public Offering of Common Stock
November 17, 2022
From G1 Therapeutics
Via GlobeNewswire
Tickers
GTHX
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.